✦ LIBER ✦

Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial

✍ Scribed by M Boaz; S Smetana; T Weinstein; Z Matas; U Gafter; A Iaina; A Knecht; Y Weissgarten; D Brunner; M Fainaru; MS Green

Book ID: 117276028
Publisher: The Lancet
Year: 2000
Tongue: English
Weight: 96 KB
Volume: 356
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(00)02783-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Probiotics in primary prevention of atop

Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial

✍ Marko Kalliomäki; Seppo Salminen; Heikki Arvilommi; Pentti Kero; Pertti Koskinen 📂 Article 📅 2001 🏛 The Lancet 🌐 English ⚖ 89 KB

Primary prevention of cardiovascular dis

Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial

✍ Haruo Nakamura; Kikuo Arakawa; Hiroshige Itakura; Akira Kitabatake; Yoshio Goto; 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 183 KB

Primary prevention of cardiovascular dis

Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial

✍ Haruo Nakamura; Kikuo Arakawa; Hiroshige Itakura; Akira Kitabatake; Yoshio Goto; 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 183 KB

Background Evidence-based treatment for hypercholesterolaemia in Japan has been hindered by the lack of direct evidence in this population. Our aim was to assess whether evidence for treatment with statins derived from western populations can be extrapolated to the Japanese population. ## Methods

The Prevention of Progression of Arteria

The Prevention of Progression of Arterial Disease and Diabetes (POPADAD) Trial: Factorial Randomised Placebo Controlled Trial of Aspirin and Antioxidants in Patients with Diabetes and Asymptomatic Peripheral Arterial Disease

✍ J. Belch; A. MacCuish; I. Campbell 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Primary prevention of cardiovascular dis

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebo-controlled trial

✍ H.M. Colhoun; D.J. Betteridge; P.N. Durrington 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Primary prevention of cardiovascular dis

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

✍ Helen M Colhoun; D John Betteridge; Paul N Durrington; Graham A Hitman; H Andrew 📂 Article 📅 2004 🏛 The Lancet 🌐 English ⚖ 199 KB